1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Eurofins Scientific SE
  6. Financials
    ERF   FR0014000MR3

EUROFINS SCIENTIFIC SE

(ERF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 8 83413 09120 89316 338--
Enterprise Value (EV)1 12 07915 33323 13218 74718 53118 311
P/E ratio 47,2x25,0x27,8x25,6x25,0x23,0x
Yield 0,70%0,99%0,92%1,14%1,21%1,31%
Capitalization / Revenue 1,94x2,41x3,11x2,48x2,45x2,28x
EV / Revenue 2,65x2,82x3,44x2,84x2,77x2,56x
EV / EBITDA 13,0x10,9x12,2x11,8x11,6x10,7x
Price to Book 3,11x3,55x4,49x3,36x3,04x2,74x
Nbr of stocks (in thousands) 178 759190 749192 035192 297--
Reference price (EUR) 49,468,610985,085,085,0
Announcement Date 03/04/202003/01/202102/22/2022---
1 EUR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 4 5635 4396 7186 5916 6807 154
EBITDA1 9311 4131 9021 5871 6031 718
Operating profit (EBIT)1 5741 0241 4731 0811 0911 176
Operating Margin 12,6%18,8%21,9%16,4%16,3%16,4%
Pre-Tax Profit (EBT)1 2726941 0578899261 009
Net income1 195539783670688748
Net margin 4,28%9,92%11,7%10,2%10,3%10,5%
EPS2 1,052,753,913,313,393,70
Dividend per Share2 0,350,681,000,971,031,12
Announcement Date 03/04/202003/01/202102/22/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 S1 2022 S2
Net sales1 1 6301 8163 4461 7603 3673 390
EBITDA --894-816-
Operating profit (EBIT) ------
Operating Margin ------
Pre-Tax Profit (EBT) ------
Net income ------
Net margin ------
EPS ------
Dividend per Share ------
Announcement Date 10/21/202102/22/202202/22/202204/21/2022--
1 EUR in Million
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 3 2452 2422 2392 4092 1941 973
Net Cash position1 ------
Leverage (Debt / EBITDA) 3,49x1,59x1,18x1,52x1,37x1,15x
Free Cash Flow1 2588731 015747751808
ROE (Net Profit / Equities) 7,09%16,5%18,8%15,3%14,0%13,7%
Shareholders' equity1 2 7543 2644 1694 3634 9195 479
ROA (Net Profit / Asset) 2,60%6,58%8,74%6,30%6,01%6,02%
Assets1 7 5148 1998 95410 63711 44812 435
Book Value Per Share2 15,919,324,225,327,931,0
Cash Flow per Share2 3,646,257,516,866,496,79
Capex1 420350495483504536
Capex / Sales 9,20%6,44%7,37%7,33%7,55%7,49%
Announcement Date 03/04/202003/01/202102/22/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Key data
Capitalization (EUR) 16 337 568 497
Capitalization (USD) 17 458 397 624
Net sales (EUR) 6 718 000 000
Net sales (USD) 7 178 884 377
Number of employees 57 992
Sales / Employee (EUR) 115 844
Sales / Employee (USD) 123 791
Free-Float 66,7%
Free-Float capitalization (EUR) 10 896 788 499
Free-Float capitalization (USD) 11 644 356 165
Avg. Exchange 20 sessions (EUR) 32 644 077
Avg. Exchange 20 sessions (USD) 34 883 604
Average Daily Capital Traded 0,20%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA